Joshua Liang
Listed on 2 Form D filings across 1+ issuer
· Executive Officer
Associated issuers
- Clover Biopharmaceuticals, Ltd. CIK 1856491 · F4
Filings (2)
-
Clover Biopharmaceuticals, Ltd.D · Apr 29, 2026 · F4 · Biotechnology$3.6MView filing →
-
Clover Biopharmaceuticals, Ltd.D · Apr 28, 2025 · F4 · Biotechnology$904.9KView filing →